Guest
Guest
Jul 03, 2026
11:27 PM
|
There is no single active patent specifically for “Tadalista 5 mg”, because Tadalista is a generic branded version of tadalafil, not an original patented drug.
The original patents for tadalafil were held by Eli Lilly and Company in collaboration with Icos Corporation. These companies developed tadalafil and marketed it under the brand name Cialis. The primary patents were filed in the 1990s and early 2000s in major markets such as the United States, Europe, and other regulated regions.
However, these patents have now expired in most countries, including the United States and India, which allowed other pharmaceutical manufacturers to produce generic tadalafil in different strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg, and higher doses.
The name TADALISTA 5 MG itself is not a patented molecule; it is a trademarked brand name owned by an Indian pharmaceutical manufacturer (commonly associated with generic drug producers). Trademarks are different from patents—they protect branding, not the drug formula.
Therefore, Tadalista 5 mg is manufactured legally under generic drug laws, where companies can produce tadalafil after patent expiration, provided they meet regulatory quality standards. The “patent location” is therefore historical rather than current, with rights now expired and no exclusive patent covering Tadalista 5 mg today.
|
